Low striatal D2 receptor binding as assessed by [I-123]IBZM SPECT in patients with writer's cramp

被引：24
|
作者：
Horstink, CA
Praamstra, P
Horstink, MWIM
Berger, HJC
Booij, J
VanRoyen, EA
机构：
[1] UNIV NIJMEGEN HOSP,DEPT NUCL MED,NL-6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,NL-1105 AZ AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT MED PSYCHOL,NL-1105 AZ AMSTERDAM,NETHERLANDS
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1997年 / 62卷 / 06期
关键词：
D O I：
10.1136/jnnp.62.6.672-a
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：672 / 673
页数：2
相关论文
共 50 条
  • [11] SPECT measurement of human striatal synaptic dopamine concentration with [I-123]IBZM
    Abi-Dargham, A
    Kegeles, L
    Malaspina, D
    Clark, S
    Gorman, J
    Mann, J
    vanHeertum, R
    Laruelle, M
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 175 - 175
  • [12] Evaluation of the distribution of dopamine D2 receptors with I-123 IBZM SPECT in unilateral dystonias.
    Lang, O
    Stejskal, L
    Ruzicka, E
    Holy, R
    Balon, HR
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 234P - 234P
  • [13] I-123 IBZM SPECT FOR ASSESSING THE DOPAMINE D2 RECEPTOR STATUS IN SCHIZOPHRENICS UNDER TREATMENT WITH TYPICAL AND ATYPICAL NEUROLEPTICS
    TATSCH, K
    SCHERER, J
    SCHWARZ, J
    KIRSCH, CM
    HAHN, K
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P74 - P74
  • [14] INVITRO AND INVIVO D2-DOPAMINE RECEPTOR-BINDING WITH [I-123] S(-)IODOBENZAMIDE ([I-123]IBZM) IN RAT AND HUMAN BRAIN
    VERHOEFF, NPLG
    BOBELDIJK, M
    FEENSTRA, MGP
    BOER, GJ
    MAAS, MAW
    ERDTSIECKERNSTE, E
    DEBRUIN, K
    VANROYEN, EA
    NUCLEAR MEDICINE AND BIOLOGY, 1991, 18 (08): : 837 - 846
  • [15] DOPAMINE-D2 RECEPTOR SCINTIGRAPHY WITH I-123 IBZM
    BAULIEU, JL
    GUILLOTEAU, D
    CHALON, S
    MARKABI, S
    GAYMARD, B
    BARRAS, MJR
    AUTRET, A
    TRANQUART, F
    BESNARD, JC
    JOURNAL DE MEDECINE NUCLEAIRE ET BIOPHYSIQUE, 1992, 16 (01): : 52 - 57
  • [16] [I-123]IBZM SPECT for imaging of striatal D-2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics
    Klemm, E
    Grunwald, F
    Kasper, S
    Menzel, C
    Broich, K
    Danos, P
    Reichmann, K
    Krappel, C
    Rieker, O
    Briele, B
    Hotze, AL
    Moller, HJ
    Biersack, HJ
    AMERICAN JOURNAL OF PSYCHIATRY, 1996, 153 (02): : 183 - 190
  • [17] IMAGING OF DOPAMINE D2 RECEPTORS USING I-123 IBZM AND SPECT IN PATIENTS WITH PARKINSONISM, WILSONS-DISEASE AND SCHIZOPHRENIA
    SCHWARZ, J
    TATSCH, K
    SCHERER, J
    OERTEL, WH
    JOURNAL OF NEUROCHEMISTRY, 1994, 63 : S28 - S28
  • [18] Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding:: A critical evaluation of the single-scan approach
    Meyer, Philipp T.
    Sattler, Bernhard
    Winz, Oliver H.
    Fundke, Rico
    Oehlwein, Christian
    Kendziorra, Kai
    Hesse, Swen
    Schaefer, Wolfgang M.
    Sabri, Osama
    NEUROIMAGE, 2008, 42 (02) : 548 - 558
  • [19] 1ST EXPERIENCE WITH THE NEW D2 LIGAND [I-123] IBE, COMPARISON WITH [I-123] IBZM
    BUCK, A
    WESTERA, G
    KUNG, HF
    ALBANI, C
    VONSCHULTHESS, GK
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P196 - P197
  • [20] Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease:: an [123I]IBZM and [123I]FP-CIT SPECT study
    Verstappen, C. C. P.
    Bloem, B. R.
    Haaxma, C. A.
    Oyen, W. J. G.
    Horstink, M. W. I. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 502 - 507
12345